URYPAB traded at 0.0250390 this Friday June 19th, increasing 0.0000296 or 0.12 percent since the previous trading session. Looking back, over the last four weeks, URYPAB gained 0.94 percent. Over the last 12 months, its price rose by 2.37 percent. Looking ahead, we forecast URYPAB to be priced at 0.0246761 by the end of this quarter and at 0.0250473 in one year, according to Trading Economics global macro models projections and analysts expectations.